Ovagen is a biotechnology company.
Ovagen has raised $2.2M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Ovagen's investors include European Investment Bank, Enterprise Ireland, European Innovation Council, HBAN, EASME.
Ovagen is headquartered in Mayo, Ireland.
Ovagen is a biotechnology company.
Ovagen is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ovagen — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/ovagen. Accessed July 19, 2026.
VCBacked. (2024). Ovagen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ovagen
{{cite web |title=Ovagen — Funding & Investors |url=https://www.vcbacked.co/company/ovagen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated